Publications by Professor Neil Sheerin - ePrints

Browsing publications by Professor Neil Sheerin.

Newcastle Authors	Title	Year
Helen Pearce Dr Emma Montgomery Professor Neil Sheerin	A Novel Case of CMV Resistance to Valganciclovir and Maribavir in a Renal Transplant Patient	2024
Dr George Kourounis Robin Nandi Dr Sam Tingle Dr Emily Glover Emily Thompson et al.	Deep Learning for Automated Boundary Detection and Segmentation in Organ Donation Photography	2024
Dr Sally Johnson Professor David Kavanagh Professor John Sayer Dr Edwin Wong Megan Bates et al.	Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort	2024
Dr Sam Tingle Abdullah Malik Dr George Kourounis Emily Thompson Dr Emily Glover et al.	Donor Time to Death and Kidney Transplant Outcomes in the Setting of a 3-Hour Minimum Wait Policy	2024
Emily Glover Professor David Kavanagh Professor Neil Sheerin	Kidney Transplantation in Patients with aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue Therapy	2024
Professor David Kavanagh Dr Vicky Brocklebank Dr Sally Johnson Professor Neil Sheerin	Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum	2024
Phil Mawson Dr Guy MacGowan Professor Neil Sheerin Professor Andrew Fisher Professor James Shaw et al.	SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients	2024
Dr Edwin Wong Lee-Ann Naidoo Sarah Winn Dr Patrick Walsh Dr Vicky Brocklebank et al.	The Annual Report of the National Renal Complement Therapeutics Centre 2022/23	2024
Emily Glover Dr Kate Smith-Jackson Dr Vicky Brocklebank Dr Valerie Wilson Dr Patrick Walsh et al.	Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome	2023
Dr Vicky Brocklebank Dr Patrick Walsh Dr Kate Smith-Jackson Dr Thomas Hallam Professor Kevin Marchbank et al.	Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study	2023
Dr Beth Gibson Chloe Connelly Dr Salta Moldakhmetova Professor Neil Sheerin	Complement activation and kidney transplantation; a complex relationship	2023
Dr Georgie Wilkins Dr Jenny Gilmour Eirini Giannoudaki Emeritus Professor John Kirby Professor Neil Sheerin et al.	Dissecting the Therapeutic Mechanisms of Sphingosine-1-Phosphate Receptor Agonism during Ischaemia and Reperfusion	2023
Sarah Thompson Chong Pang Dr Tom Hellyer Dr Jonathan Scott Professor John Simpson et al.	Nitration of Chemokine CXCL8 acts as a natural mechanism to limit acute inflammation	2023
Dr Ruyue Sun Dr Long Xie Rebecca Russell Dr Edwin Wong Professor Neil Sheerin et al.	Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue	2023
Dr Edwin Wong Sarah Winn Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al.	The Annual Report of the National Renal Complement Therapeutics Centre 2021/22	2023
Professor Neil Sheerin	Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: an indirect comparison using clinical trial data	2022
Emily Thompson Dr Avinash Sewpaul Lucy Bates Dr Sam Tingle Dr Aldi Situmorang et al.	MicroRNA antagonist therapy during normothermic machine perfusion of donor kidneys	2022
Professor Neil Sheerin	Research engagement by British early-career practitioners in nephrology: A multidisciplinary survey	2022
Sarah Dunn Abishek Umashankar Andrew Bryant Dr Sonya Carnell Dr Thomas Chadwick et al.	Saftey and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study	2022
Professor Neil Sheerin	A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function	2021
Dr Emily Thompson Chloe Connelly Professor Simi Ali Professor Neil Sheerin Professor Colin Wilson et al.	Cell therapy during machine perfusion	2021
Nina Jordan Dr Sam Tingle Victoria Shuttleworth Katie Cooke Dr Rachael Redgrave et al.	MiR-126-3p Is Dynamically Regulated in Endothelial-to-Mesenchymal Transition during Fibrosis	2021
Dr Jehill Parikh Professor Peter Thelwall Professor Neil Sheerin	Motion correction of free-breathing magnetic resonance renography using model-driven registration	2021
Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Dr Avinash Sewpaul Rodrigo Figueiredo et al.	Novel delivery of cellular therapy to reduce ischaemia reperfusion injury in kidney transplantation	2021
Dr Edwin Wong Sarah Winn Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al.	The Annual Report of the National Renal Complement Therapeutics Centre 2020/21	2021
Dr Tom Altmann Dr Stephen Owens Dr Dipayan Mitra Professor Neil Sheerin Professor David Kavanagh et al.	Complement Factor I deficiency: a potentially treatable cause of fulminant cerebral inflammation	2020
Dr Jack Leslie Dr Marina Garcia Macia Dr Saimir Luli Dr Julie Worrell William Reilly et al.	c-Rel orchestrates energy-dependant epithelial and macrophage reprogramming in fibrosis	2020
Dr Sam Tingle Dr Avinash Sewpaul Lucy Bates Dr Emily Thompson Victoria Shuttleworth et al.	Dual microRNA blockade increases expression of antioxidant protective proteins; implications for ischaemia reperfusion injury	2020
Emily Glover Dr Ally Speight Dr Despina Televantou Dr Stephanie Needham Professor Neil Sheerin et al.	Immunosuppression-induced clonal T-cell lymphoproliferative disease causing severe diarrhoea mimicking coeliac disease following renal transplantation: a case report	2020
Professor Neil Sheerin	KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.	2020
Dr Vicky Brocklebank Dr Kate Smith-Jackson Dr Patrick Walsh Professor Kevin Marchbank Professor Claire Harris et al.	Long-term outcomes and response to treatment in DGKE nephropathy	2020
Dr Ian Logan Dr Charlie Tomson Professor Neil Sheerin Dr Tim Ellam	Obesity, Sex, Race, and Early Onset Hypertension: Implications for a Refined Investigation Strategy	2020
Professor Neil Sheerin	Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation	2020
Dr Edwin Wong Lisa Batchelor Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al.	The Annual Report of the National Renal Complement Therapeutics Centre 2019/20	2020
Dr Gareth Parry Professor John Dark Professor Neil Sheerin	The Impact of Severe Acute Kidney Injury Requiring Renal Replacement Therapy on Survival and Renal Function of Heart Transplant Recipients – A UK Cohort Study	2020
Dr Jamie Willows Professor Neil Sheerin	The role of complement in kidney disease	2020
Beatriz Martinez Burgo Emeritus Professor John Kirby Professor Neil Sheerin Professor Simi Ali	A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation	2019
Lucy Bates Professor Neil Sheerin	A urinary microRNA panel that is an early predictive biomarker of delayed graft function following kidney transplantation	2019
Dr Tracy Finch Dr Gregory Maniatopoulos Dr Chris Gibbins Professor Neil Sheerin Dr Suren Kanagasundaram et al.	Acute kidney injury electronic alerts: mixed methods Normalization Process Theory evaluation of their implementation into secondary care in England	2019
Dr Jamie Willows Dr Ian Logan Professor Neil Sheerin Dr Charlie Tomson Dr Tim Ellam et al.	Changing Protein Permeability with Nephron Loss; Evidence for a Human Remnant Nephron Effect	2019
Dr Mustafa Sevinc Susan Stamp David Talbot Professor Neil Sheerin	Comparison of the outcome of kidney transplantation after pulsatile or continuous ex vivo hypothermic machine perfusion of kidneys donated after cardiac death: analysis of kidney pairs	2019
Professor Neil Sheerin	Eculizumab Prevents Thrombotic Microangiopathy in Patients With Atypical Hemolytic Uremic Syndrome in a Long-Term Observational Study	2019
Professor Neil Sheerin	Haemolytic uremic syndrome: diagnosis and management	2019
Laura Ferreras Dr Anna Moles Fernandez Dr Aldi Situmorang Imogen Wilson Katie Cooke et al.	Heparan sulfate in chronic kidney diseases: exploring the role of 3-O-sulfation	2019
Professor Fiona Oakley Lucy Gee Professor Neil Sheerin Dr Lee Borthwick	Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy	2019
Dr Aldi Situmorang Professor Neil Sheerin	Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction	2019
Professor Neil Sheerin	Outcomes in Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in a Long-term Observational Study	2019
Dr Lu Wang Professor Andrew Fisher Professor Neil Sheerin Professor John Dark	Severe acute kidney injury after cardiac transplantation is a marker of poor early outcome and impacts on late renal function -- a UK cohort study	2019
Dr Edwin Wong Jo Stout Jalibani Ndebele Angela Watt Lisa Batchelor et al.	The Annual Report of the National Renal Complement Therapeutics Centre 2018/19	2019
Dr Lu Wang Dr Gareth Parry Professor Neil Sheerin Professor John Dark	The need for haemofiltration after lung transplantation is a marker of poor early outcomes, but has no deleterious long-term renal effect -- a UK cohort study	2019
Emily Glover Professor Neil Sheerin	Urinary tract infection	2019
Dr Emma Montgomery Professor Neil Sheerin	Glomerular filtration rate: new age- and gender- specific reference ranges and thresholds for living kidney donation	2018
Professor Neil Sheerin	Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study	2018
Emily Glover Nina Jordan Professor Neil Sheerin Professor Simi Ali	Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction	2018
Dr Edwin Wong Jo Stout Jalibani Ndebele Angela Watt Dr Michal Malina et al.	The Annual Report of the National Renal Complement Therapeutics Centre 2017/18	2018
Victoria Shuttleworth Dr Luke Gaughan Lotfia Nawafa Professor Neil Sheerin Dr Ian Logan et al.	The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3	2018
Catriona Barker Sarah Thompson Dr Graeme O'Boyle Professor Neil Sheerin Professor Simi Ali et al.	CCL2 nitration is a negative regulator of chemokine-mediated inflammation	2017
Dr Vicky Brocklebank Dr Sally Johnson Dr Patrick Walsh Dr Edwin Wong Dr Larissa Kerecuk et al.	Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland	2017
Dr Jennifer Duff Professor Neil Sheerin Professor John Sayer Professor Gavin Hudson Professor Patrick Chinnery et al.	Mutations in mitochondrial DNA causing tubulointerstitial kidney disease	2017
Professor Neil Sheerin	Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis	2017
Sarah Thompson Beatriz Martinez Burgo Emeritus Professor John Kirby Professor Neil Sheerin Professor Simi Ali et al.	Regulation of chemokine function: The roles of GAG-binding and post-translational nitration	2017
Dr Edwin Wong Dr Sally Johnson Professor Neil Sheerin Professor David Kavanagh	The Annual Report of the National Renal Complement Therapeutics Centre 2016/2017	2017
Dr Amy Fearn Dr Aldi Situmorang Christopher Fox Professor Fiona Oakley Rachel Howarth et al.	The NF-kB1 is a key regulator of acute but not chronic renal injury	2017
Professor Neil Sheerin Professor David Kavanagh Professor Tim Goodship Dr Sally Johnson	A national specialised service in England for atypical haemolytic uraemic syndrome – the first year’s experience	2016
Dr Suren Kanagasundaram Dr Andrew Sims Dr David Price Professor Neil Sheerin	Computerised clinical decision support for the early recognition and management of acute kidney injury: a qualitative evaluation of end-user experience	2016
Susan Stamp David Talbot Professor Neil Sheerin	Ex Vivo Perfusion Characteristics of Donation After Cardiac Death Kidneys Predict Long-Term Graft Survival	2016
Christopher Fox Dr Pasquale Cocchiaro Professor Fiona Oakley Rachel Howarth Krystena Callaghan et al.	Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease	2016
Beatriz Martinez Burgo Professor Simi Ali Jennifer Kirby Professor Neil Sheerin	Ischemia-Reperfusion Injury Following Transplantation: Implications for the Modulation of CXCL8 Chemokine Function.	2016
Professor Neil Sheerin	Long-Term follow-up study of Eculizumab for prevention of thrombotic microangiopathy in patients with atypical hemolytic uremic syndrome	2016
Dr Pasquale Cocchiaro Christopher Fox Rachel Howarth Dr Katrina Wood Professor Neil Sheerin et al.	Lysosomal Protease Cathepsin D, new player in apoptosis during acute kidney injury	2016
Dr Pasquale Cocchiaro Christopher Fox Nicholas Tregidgo Rachel Howarth Dr Katrina Wood et al.	Lysosomal protease cathepsin D; a new driver of apoptosis during acute kidney injury	2016
Professor Tim Goodship Professor Neil Sheerin	Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis.	2016
Professor Neil Sheerin	Renal Outcome with Eculizumab in Patients with aHUS with Native and Transplanted Kidneys: Pooled Analysis of 100 Patients.	2016
Dr Gus Brooks Dr Aaron Liew Dr Helen Marshall Dr Ali Aldibbiat Professor Neil Sheerin et al.	De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes	2015
Dr Isabel Pappworth Dr Edwin Wong Professor Neil Sheerin Professor Kevin Marchbank	An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy	2015
Professor Neil Sheerin	Behaviour of Transplanted Tumours and Role of Matching in Rejection	2015
Amy Fearn Professor Neil Sheerin	Complement activation in progressive renal disease	2015
Professor Neil Sheerin	Eculizumab Prevents Thrombotic Microangiopathy: Long-Term Follow-up Study of Patients with Atypical Hemolytic Uremic Syndrome	2015
Professor Tim Goodship Professor Neil Sheerin	Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies	2015
Professor Neil Sheerin Dr Andrew Sims Dr David Price Dr Suren Kanagasundaram	Electronic Clinical Decision Support for the Early Recognition and Management of Acute Kidney Injury: Qualitative Evaluation of End-User Experience	2015
Dr Andrew Sims Professor Neil Sheerin Dr David Price Dr Suren Kanagasundaram	Electronic clinical decision support for the early recognition and management of acute kidney injury: quantitative evaluation of outcomes	2015
Dr Mustafa Sevinc Susan Stamp Dr Noel Carter Professor Neil Sheerin David Talbot et al.	Ex Vivo perfusion characteristics of DCD kidneys predict long-term graft survival	2015
Dr Edwin Wong Dr Jeremy Palmer Professor Neil Sheerin Dr Isabel Pappworth	FH1-5^(18-20) ameliorates experimental C3 glomerulopathy; generation and testing of a murine version for further pre-clinical experiments	2015
Dr Sarah McCloskey Professor Neil Sheerin	From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions	2015
Laura Ferreras Professor Neil Sheerin Emeritus Professor John Kirby Professor Simi Ali	Mechanisms of renal graft chronic injury and progression to interstitial fibrosis	2015
Dr Faryal Afridi Dr Rachael Coates Professor Neil Sheerin David Talbot	Outcomes of ABOi Renal Transplants: A single centre experience over a seven year period	2015
Dr Edwin Wong Rachel Challis Professor Neil Sheerin Dr Sally Johnson Professor David Kavanagh et al.	Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS)	2015
Christopher Fox Rachel Howarth Krystena Callaghan Dr Katrina Wood Professor Fiona Oakley et al.	Pepstatin A improves renal fibrosis by impairing UPA lysosomal recycling	2015
Dr Luca Ermini Dr William Howell Professor Neil Sheerin	Systematic assessment of the influence of complement gene polymorphisms on kidney transplant outcome	2015
Dr Ian Logan Victoria Shuttleworth Dr Luke Gaughan Lotfia Nawafa Professor Neil Sheerin et al.	The Lysine Methyltransferase SETD7 is critical for TGF B-1 driven fibrosis	2015
Professor Tim Goodship Dr Alison Brown Professor Neil Sheerin	Thrombotic microangiopathy as a cause of chronic kidney transplant dysfunction: a case report demonstrating successful treatment with Eculizumab	2015
Dr Caroline Wilson Dr Lindsay Murphy Jack Leslie Dr Stuart Kendrick Jeremy French et al.	Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease	2015
Professor Neil Sheerin	Urinary tract infection	2015
Professor Neil Sheerin Dr Judith Hall Rob Pickard	E. coli inhibits innate immunity to facilitate pyelonephritic infections	2014
Professor David Kavanagh Professor Neil Sheerin	Management of hemolytic uremic syndrome	2014
Dr James Frith Professor Fai Ng Professor Chris Day Dr Brendan Payne Professor Neil Sheerin et al.	Orthostatic intolerance is common in chronic disease - A clinical cohort study	2014
Professor Neil Sheerin	Prognosis and management of chronic kidney disease (CKD) at the end of life	2014
Professor Neil Sheerin	Thrombotic microangiopathies	2014
Dr Ian Logan Professor Neil Sheerin	Anticoagulation and kidney injury: rare observation or common problem?	2013
Professor Simi Ali Professor Neil Sheerin	Biomarkers of acute injury: predicting the long-term outcome after transplantation	2013
Professor Neil Sheerin	Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol	2013
Professor Tim Goodship Professor Neil Sheerin	Efficacy of Eculizumab in atypical hemolytic uremic syndrome (aHUS) patients with or without prior transplant	2013
Dr Edwin Wong Mark Brady Professor Neil Sheerin	Severe intestinal oedema due to nephrotic syndrome	2013
Professor Neil Sheerin Professor Tim Goodship	Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome	2013
Dr Luca Ermini Professor Tim Goodship Dr Lisa Turnbull Professor Heather Cordell Dr Veronique Fremaux-Bacchi et al.	Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.	2012
Dr Luca Ermini Dr Ian Wilson Professor Tim Goodship Professor Neil Sheerin	Complement polymorphisms: Geographical distribution and relevance to disease	2012
Dr Valerie Wilson Dr Iain Moore Dr Lisa Turnbull Professor Kevin Marchbank Professor Neil Sheerin et al.	Postpartum aHUS Secondary to a Genetic Abnormality in Factor H Acquired Through Liver Transplantation	2012
Dr Eva-Maria Hunze Professor Neil Sheerin Professor Kevin Marchbank	Targeting the glomerular basement membrane to control unwanted complement activation	2012
Dr Amy Fearn Professor Neil Sheerin	Complement activation drives interstitial inflammation and fibrosis in models of kidney disease	2011
Dr Luca Ermini Professor Tim Goodship Dr Lisa Turnbull Professor Heather Cordell Dr Veronique Fremaux-Bacchi et al.	Genetic variants in CFH and CD46 are the major susceptibility factors for aHUS-An association study of multiple complement genes	2011
Dr Ellen Hatch Professor Louise Parker Emeritus Professor John Kirby Professor Neil Sheerin	Infiltrating renal T cells are activated and respond to self antigen	2011
Dr Alison Brown Professor Tim Goodship Professor Neil Sheerin Professor Derek Manas	Successful Treatment of De Novo Posttransplant Thrombotic Microangiopathy With Eculizumab	2011
Dr Amy Fearn Dr Steven Lisgo Dr Steven Darby Professor Neil Sheerin	The influence of complement activation on chronic renal inflammation and fibrosis	2011
Dr Amy Fearn Dr Steven Lisgo Dr Steven Darby Professor Neil Sheerin	The influence of complement activation on chronic renal inflammation and fibrosis	2011
Professor Neil Sheerin	Trajectories of Illness in Stage 5 Chronic Kidney Disease: A Longitudinal Study of Patient Symptoms and Concerns in the Last Year of Life	2011
Professor Neil Sheerin	Endogenous Ligands for TLR2 and TLR4 Are Not Involved in Renal Injury following Ureteric Obstruction	2010
Dr Amy Fearn Professor Neil Sheerin	Pivotal role of CD4⁺ T cells in renal fibrosis following ureteric obstruction	2010
Dr Amy Fearn Professor Neil Sheerin	The influence of complement activation on chronic renal inflammation and fibrosis	2010
Professor Neil Sheerin	A Novel Role for Nephrin in the Maintenance of Glomerular Structure	2009
Dr Ellen Hatch Professor Neil Sheerin	C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy	2009
Professor Neil Sheerin	Complement activation and progression of chronic kidney disease	2009
Dr V Ingham Professor Neil Sheerin	Diabetic glomerular disease: Pitfalls in diagnosis	2009
Emerita Professor Julia Newton Professor Neil Sheerin	Fatigue in early renal disease	2009
Professor Neil Sheerin	Illness trajectories: an important concept in the management of kidney failure	2009
Dr Amy Fearn Professor Neil Sheerin	Role for CD4⁺ T cells in Renal Fibrosis	2009
Professor Neil Sheerin	Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E-coli by human tubular epithelial cells	2009
Dr Amy Fearn Professor Fiona Oakley Professor Derek Mann Professor Neil Sheerin	Tubulointerstitial inflammation and fibrosis is not influenced by deficiency of the regulatory transcription factor NFκB1	2009
Dr Amy Fearn Professor Fiona Oakley Professor Derek Mann Professor Neil Sheerin	Tubulointerstitial inflammation and fibrosis is not influenced by deficiency of the regulatory transcription factor NFκB1	2009
Professor Neil Sheerin	Understanding Symptoms in Patients with Advanced Chronic Kidney Disease Managed without Dialysis: Use of a Short Patient-Completed Assessment Tool	2009
Professor Neil Sheerin	Dialysis or not? A comparative survival study of patients over 75 years of age with chronic kidney disease stage - Reply	2008
Dr Daniela Lee Professor Neil Sheerin	Paranoid Psychosis and Myoclonus: Flecainide Toxicity in Renal Failure	2008
Professor Neil Sheerin	Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation	2008
Professor Neil Sheerin	Reply	2008
Professor Neil Sheerin	Should Complement Activation Be a Target for Therapy in Renal Transplantation?	2008
Professor Neil Sheerin	Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury	2008
Professor Neil Sheerin	The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli	2008
Professor Neil Sheerin	Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5	2007
Professor Neil Sheerin	Mechanisms of disease: the complement system in renal injury - new ways of looking at an old foe	2007
Professor Neil Sheerin	Accumulation of Immune Complexes in Glomerular Disease Is Independent of Locally Synthesized C3	2006
Professor Neil Sheerin	CD46 (Membrane Cofactor Protein) Acts as a Human Epithelial Cell Receptor for Internalization of Opsonized Uropathogenic Escherichia coli	2006
Professor Neil Sheerin	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection	2006
Professor Neil Sheerin	Influence of Donor C3 Allotype on Late Renal-Transplantation Outcome	2006
Professor Neil Sheerin	Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products	2006
Professor Neil Sheerin	Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis	2005
Dr Muhammad Khan Professor Neil Sheerin	Urinary tract infections: new insights into a common problem	2005
Professor Neil Sheerin	Autoimmune renal injury in C3- and C4-deficient mice: a histological and functional study	2004
Dr Zahed Chowdhury Professor Neil Sheerin	Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infection	2004
Professor Neil Sheerin	The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells	2004
Professor Neil Sheerin	Urinary tract infections: advances and new therapies	2004
Professor Neil Sheerin	Positron emission tomography in a patient with renal malacoplakia	2003
Professor Neil Sheerin	Leaked protein and interstitial damage in the kidney: is complement the missing link?	2002
Professor Neil Sheerin	Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli	2001
Professor Neil Sheerin	Late allograft loss due to recurrence of p-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis	2001
Professor Neil Sheerin	Protection and injury: the differing roles of complement in the development of glomerular injury	2001
Professor Neil Sheerin	Spontaneous Abdominal Hemorrhage with AA-amyloidosis and Vasculitis in a Patient with Rheumatoid Arthritis	2001
Professor Neil Sheerin	Successful medical treatment of acute bilateral emphysematous pyelonephritis	2000
Professor Neil Sheerin Michael Carroll	Altered distribution of intraglomerular immune complexes in C3-deficient mice	1999
Professor Neil Sheerin	Apical Proteins Stimulate Complement Synthesis by Cultured Human Proximal Tubular Epithelial Cells	1999
Professor Neil Sheerin	Chronic Interstitial Damage in Proteinuria. Does Complement Mediate Tubulointerstitial Injury?	1999
Professor Neil Sheerin	Contribution of renal secreted complement C3 to the circulating pool in humans	1999
Professor Neil Sheerin	In vitro erythrophagocytosis by renal tubular cells and tubular toxicity by haemoglobin and iron	1999